// company-profile

Tvardi Therapeutics, Inc.

TVRD
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings78Insiders23
// api This Tvardi Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares. Buying was led by Smith Cynthia.

// 90-day insight

Over the last 90 days, Tvardi Therapeutics, Inc. insiders bought $0 across 5 transactions with no open-market sales.

  • Most active insider: Smith Cynthia with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Tvardi Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$8.3M
QoQ change
-19.1%
Reporting period
2026-03-31
#1
Slate Path Capital LP
CIK 1559706
$2.2M
704K shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$1.1M
345K shares
#3
AMERICAN FINANCIAL GROUP INC
CIK 1042046
$711,236
224K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 9, 2026Smith CynthiaTVRD
Award
6,000$0.00$0K
Jun 9, 2026WYZGA MICHAEL STVRD
Award
6,000$0.00$0K
Jun 9, 2026Shah SujalTVRD
Award
6,000$0.00$0K
Jun 9, 2026Shiff Susan Ph.D.TVRD
Award
6,000$0.00$0K
Jun 9, 2026HALL WALLACE L JRTVRD
Award
6,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.